Henderson Jane — SEC insider filings

SEC reporting owner CIK 1422304. 37 insider filings on record with FilingPulse; latest filed 2026-10-26.

Transaction summary — filings shown

Covers all 37 filings on record, filed 2021-05-10 to 2026-10-26. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Apogee Therapeutics, Inc. (APGE)Chief Financial Officer17—23 legs · 33,500 sh · $2,382,3678
Akero Therapeutics, Inc. (AKRO)Director8—3 legs · 43,000 sh · $2,309,05616
IVERIC bio, Inc. (ISEE)Director5——17
CARGO Therapeutics, Inc. (CRGX)Director3——4
Lycia Therapeutics, Inc. (LYCA)Director2——2
Adagio Therapeutics, Inc. (ADGI)Chief Financial Officer1——1
Sesen Bio, Inc. (SESN)Director1——1

Insider filings — Henderson Jane

FiledFormIssuerReported transactionsSource
2026-10-264Lycia Therapeutics, Inc. (LYCA)Grant/award (A): 57,666 (derivative) @ $0 · Grant/award (A): 20,000 (derivative) @ $0EDGAR
2026-10-223Lycia Therapeutics, Inc. (LYCA)Holdings only — no transactions reportedEDGAR
2026-09-034Apogee Therapeutics, Inc. (APGE)Disposition to issuer (D): 158,371 · Disposition to issuer (D): 175,345 (derivative) · Disposition to issuer (D): 124,962 (derivative) · Disposition to issuer (D): 83,690 (derivative)EDGAR
2026-07-244Apogee Therapeutics, Inc. (APGE)Gift (G): 15,000 @ $0EDGAR
2026-05-044Apogee Therapeutics, Inc. (APGE)Sale (S): 811 @ $81.02 · Sale (S): 900 @ $82.60 · Sale (S): 289 @ $83.16EDGAR
2026-04-174Apogee Therapeutics, Inc. (APGE)Sale (S): 2,000 @ $90EDGAR
2026-04-034Apogee Therapeutics, Inc. (APGE)Sale (S): 900 @ $84.46 · Sale (S): 1,100 @ $85.46EDGAR
2026-03-274Apogee Therapeutics, Inc. (APGE)Sale (S): 2,000 @ $85EDGAR
2026-03-044Apogee Therapeutics, Inc. (APGE)Sale (S): 300 @ $68.27 · Sale (S): 300 @ $69.43 · Sale (S): 994 @ $70.45 · Sale (S): 406 @ $71.66EDGAR
2026-02-044Apogee Therapeutics, Inc. (APGE)Sale (S): 792 @ $65.21 · Sale (S): 1,108 @ $66.15 · Sale (S): 100 @ $66.89EDGAR
2026-01-064Apogee Therapeutics, Inc. (APGE)Sale (S): 1,920 @ $74.13 · Sale (S): 4,080 @ $75.20 · Sale (S): 2,000 @ $80 · Grant/award (A): 83,690 (derivative) @ $0EDGAR
2025-12-234Apogee Therapeutics, Inc. (APGE)Sale (S): 1,500 @ $80EDGAR
2025-12-094Akero Therapeutics, Inc. (AKRO)Disposition to issuer (D): 9,398 · Disposition to issuer (D): 26,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 13,000 (derivative) · Disposition to issuer (D): 13,000 (derivative) · +1 moreEDGAR
2025-12-054Apogee Therapeutics, Inc. (APGE)Sale (S): 1,500 @ $75EDGAR
2025-11-284Apogee Therapeutics, Inc. (APGE)Sale (S): 1,500 @ $70EDGAR
2025-11-144Apogee Therapeutics, Inc. (APGE)Sale (S): 2,000 @ $65EDGAR
2025-11-134Apogee Therapeutics, Inc. (APGE)Sale (S): 1,000 @ $60EDGAR
2025-08-194CARGO Therapeutics, Inc. (CRGX)Disposition to issuer (D): 25,000 (derivative)EDGAR
2025-08-124Akero Therapeutics, Inc. (AKRO)Option exercise (M): 3,000 @ $7.01 · Sale (S): 3,000 @ $47.46 · Option exercise (M): 3,000 (derivative) @ $0EDGAR
2025-06-204CARGO Therapeutics, Inc. (CRGX)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2025-06-054Akero Therapeutics, Inc. (AKRO)Grant/award (A): 9,398 @ $0EDGAR
2024-12-114Apogee Therapeutics, Inc. (APGE)Grant/award (A): 124,962 (derivative) @ $0EDGAR
2024-08-234Apogee Therapeutics, Inc. (APGE)Sale (S): 6,000 @ $48.26EDGAR
2024-06-114Akero Therapeutics, Inc. (AKRO)Grant/award (A): 26,000 (derivative) @ $0EDGAR
2024-06-064CARGO Therapeutics, Inc. (CRGX)Grant/award (A): 19,785 (derivative) @ $0 · Grant/award (A): 39,402 (derivative) @ $0EDGAR
2023-12-204Apogee Therapeutics, Inc. (APGE)Grant/award (A): 175,345 (derivative) @ $0EDGAR
2023-07-134IVERIC bio, Inc. (ISEE)Disposition to issuer (D): 22,088 · Disposition to issuer (D): 7,500 (derivative) · Disposition to issuer (D): 32,000 (derivative) · Disposition to issuer (D): 16,000 (derivative) · Disposition to issuer (D): 16,000 (derivative) · Disposition to issuer (D): 16,000 (derivative) · +2 moreEDGAR
2023-06-274Akero Therapeutics, Inc. (AKRO)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-06-214Akero Therapeutics, Inc. (AKRO)Option exercise (M): 40,000 @ $7.01 · Sale (S): 17,502 @ $53.79 · Sale (S): 22,498 @ $54.46 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2023-05-194IVERIC bio, Inc. (ISEE)Grant/award (A): 7,500 (derivative) @ $0EDGAR
2023-05-154IVERIC bio, Inc. (ISEE)Option exercise (M): 14,588 · Option exercise (M): 14,588 (derivative) @ $0EDGAR
2022-06-034Akero Therapeutics, Inc. (AKRO)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-05-134IVERIC bio, Inc. (ISEE)Option exercise (M): 7,500 · Option exercise (M): 7,500 (derivative) @ $0 · Grant/award (A): 14,588 (derivative) @ $0 · Grant/award (A): 23,186 (derivative) @ $0EDGAR
2022-02-014Adagio Therapeutics, Inc. (ADGI)Grant/award (A): 175,000 (derivative) @ $0EDGAR
2021-06-034Akero Therapeutics, Inc. (AKRO)Grant/award (A): 13,000 (derivative) @ $0EDGAR
2021-05-204IVERIC bio, Inc. (ISEE)Grant/award (A): 15,500 (derivative) @ $0 · Grant/award (A): 7,500 (derivative) @ $0EDGAR
2021-05-104Sesen Bio, Inc. (SESN)Grant/award (A): 92,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-05-05 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1422304 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs